about
AKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung CancerSpheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftmentThe role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.Mutant AKT1-E17K is oncogenic in lung epithelial cellsThe Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.Co-regulated expression of alpha and beta mRNAs encoding HLA-DR surface heterodimers is mediated by the MHCII RNA operonDetection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve PatientsAberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.Contribution of PKB/AKT signaling to thyroid cancer.Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest.Multivisceral resection for occlusive colorectal cancer: Is it justified?Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung.Loss of p27 expression through RAS-->BRAF-->MAP kinase-dependent pathway in human thyroid carcinomas.Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems.Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells.Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data.Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing.The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface poolEffect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue
P50
Q28550038-2A0A6865-BA49-4F5A-8D04-263FF7999D4CQ28742459-C0ED2C35-8229-4FF5-A422-0635F2ECE6AEQ33451434-F8A14DC0-7EDD-4062-BA79-2CCE9AD99821Q34170007-DDFF1958-103C-4483-BF96-CF70E53B0D40Q34247062-A3489CB8-A4FA-43F7-86F9-45DE2E3965CCQ36545440-AC104EF5-E13E-41C8-A1F2-1672A34A7969Q36618973-8E9F7D86-4296-4B06-87BB-5BED56DEA55BQ36740824-80DB182D-B276-424C-A6CE-F3181BBFE400Q37286311-2C9BD452-8CFA-4EC0-9967-5999F4DE38A1Q37667783-323B02D4-DFD9-409E-8301-6705432CDB95Q37825213-F3408DBE-B571-4659-84C1-C86F874280E5Q38642842-042F9201-4001-4A24-9554-397D8881E055Q39375118-3F83F24A-57FF-482A-9F02-26B14F885D32Q39615479-3C5256A6-6104-4A01-A711-6D6CCE6F03CBQ40015643-F54F067B-36BA-41CF-95D3-F7CF6F76FEE4Q40046090-CDB377BA-63EE-46FB-A822-AE6C26B4C172Q40105319-45DE164F-E4C6-4CF4-AEDC-9F3608D305D4Q40180706-2FFF4304-6E8F-4F56-8776-7BB20A89E171Q41002538-0368A805-A8BB-41F2-8F06-42A023D12E04Q42292341-6D8A5495-3341-4307-B1EA-4C2B0FFD9195Q46371383-8C718EC7-DC77-42E5-988A-30DC2B0FFAA1Q46979191-01567A99-1B04-43A5-874F-DEFF4E0797C0Q52582448-1B77EFD5-8AFB-4B82-B289-DD9C463C0F39Q53348388-7DD0EF78-598F-42A8-9995-4A530DC07BA7Q54546392-3F617D9F-346D-4B7F-AA87-8205AA2DDA29Q55027358-25AA44AD-BF9C-4CEF-B445-21D064348AF0Q55223250-1EEFE744-35FD-4D5D-9D9B-F4921410C24DQ58988119-B112AD25-A9E5-413E-9A4F-341649AFDB29Q58988160-5A4965D9-8505-43A1-B295-53442284553D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Donatella Malanga
@ast
Donatella Malanga
@en
Donatella Malanga
@es
Donatella Malanga
@nl
Donatella Malanga
@sl
type
label
Donatella Malanga
@ast
Donatella Malanga
@en
Donatella Malanga
@es
Donatella Malanga
@nl
Donatella Malanga
@sl
prefLabel
Donatella Malanga
@ast
Donatella Malanga
@en
Donatella Malanga
@es
Donatella Malanga
@nl
Donatella Malanga
@sl
P106
P1153
23995533000
P21
P31
P496
0000-0002-0491-7698